Pembrolizumab - Globe Thesis

Keyword [Pembrolizumab] Result: 1 - 14 \| Page: 1 of 1
1.	A Clinical Observation Of Pembrolizumab In PD-L1 Positive Advanced NSCLC Patients And Its Correlation With The Expression Of PD-1 And TIM-3 In Peripheral Blood T Cells
2.	The Clinical Observation Of NK/T-cell Lymphoma Patients Treated With Pembrolizumab And The Impacting Factor Of PD-L1 Expression
3.	Efficacy And Treatment-related Toxicities Associated With PD-1/PD-L1 Inhibitors In Previously-treated Advanced Non-small Cell Lung Cancer(NSCLC):Systematic Review And Meta-analysis
4.	The Incidence And Risk Factors Of Pneumonitis In Patients Treated With Immune Checkpoint Inhibitors
5.	Clinical Pathological Characteristics Of Liver Injury Associated With Immune Checkpoint Inhibitors
6.	Incidence And Risk Of PD-1/PD-L1 Inhibitors Related Pneumonitis In Patients With Advanced Cancer
7.	Pembrolizumab-an Anti-PD-1 Agent In Treatment Of Tripe Negative Breast Cancer: Recent Findings And Next Move
8.	The Role Of Circulating Tumor DNA Dynamically Monitored By Next-Generation Sequencing In Predicting The Efficacy Of Pembrolizumab Monotherapy For Non-small Cell Lung Cancer
9.	Value Evaluation Of Pembrolizumab As A Single Agent In The First-line Treatment Of Advanced Non-small Cell Lung Cancer
10.	Efficacy And Immune-Related Adverse Events Induced By PD-1/PD-L1 Inhibitors As First-Line Treatment For Advanced Non-Small Cell Lung Cancer:a Meta-Analysis Of Randomized Controlled Trials
11.	Cost-utility Analysis Of PD-1/PD-L1 Inhibitors As First-line Treatment For Advanced Lung Cancer
12.	Combination Of EP And Anti-PD-1 Pathway Or Anti-CTLA-4 For The Phase ? Trial Of Small Cell Lung Cancer:A Meta-analysis
13.	Analysis Of Differential Genes That Affect The Efficacy Of Nivolumab And Pembrolizumab In The Treatment Of Non-small Cell Lung Cancer Based On GEO Database
14.	Meta-analysis Of The Efficacy And Safety Of PD-1 Inhibitors In The Treatment Of Advanced Tumors
<<First <Prev Next> Last>> Jump to